Press Releases

Press Release: Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO — August 17, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will […]

Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide

Following a successful first year supporting 100 pioneering research projects, Atomwise opens a new round of awards to academic researchers. Atomwise Inc., a leader in using Artificial Intelligence (AI) for drug screening and design, has announced that 100 academic projects have received an Artificial Intelligence Molecular Screen (AIMS) Award in the first year of the […]


June 1, 2018
Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner for the Global Pharmaceutical Industry

Atomwise Inc. today announced it has raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group, in support of its mission to become the preferred artificial intelligence partner for the world’s leading pharmaceutical, biotech, and agrochemical companies. Prior investors, including Y Combinator, Khosla Ventures, and DFJ participated […]


March 7, 2018
Monsanto and Atomwise Collaborate to Discover New Crop Protection Options Using Artificial Intelligence Technology

Monsanto Company and Atomwise have formed a unique research collaboration to increase the speed and probability of discovering and developing new crop protection products using artificial intelligence. “Each growing season, farmers around the world are challenged with yield-robbing pests and diseases, yet the average crop protection product takes up to 11 years and more than […]


June 14, 2017
Atomwise Opens Applications for Historic AI Drug Discovery Awards

New initiative puts potential medicines chosen by artificial intelligence into the hands of one hundred researchers San Francisco, CA – April 19, 2017 – Atomwise Inc. seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. The Artificial Intelligence Molecular Screen (AIMS) program is designed to […]


April 9, 2017
Atomwise Raises $6 Million to Advance Artificial Intelligence for Drug Discovery

Atomwise Inc. today announced it has raised $6 million in seed funding from five leading, science-focused venture capital firms: Data Collective, which led the funding, Khosla Ventures, DFJ, AME Cloud Ventures, and OS Fund. “Having any one of these investors behind Atomwise would be remarkable,” said Co-founder and CEO, Dr. Abraham Heifets. “Having all five […]


June 3, 2015
Atomwise finds first evidence towards new Ebola treatments

Four months ago, Atomwise launched a virtual search for safe, existing medicines that could be repurposed to treat the Ebola virus. This week, the first evidence has been found that two drugs predicted by Atomwise’s artificial intelligence technology may significantly reduce Ebola infectivity. These drugs were intended for unrelated illnesses and their potential to treat […]


March 24, 2015